Qlife

Qlife is a Swedish-listed medtech and diagnostics company focused on decentralized, clinical-grade blood biomarker testing for use at home, in pharmacies, and at the point of care. Its core product is the Egoo Health platform, which combines a small analyzer, single-use test capsules, and software to deliver lab-grade biomarker data outside traditional laboratory settings. The company’s current portfolio spans general health, rare disease, and hospital-at-home use cases, with commercial sales already reported for its CRP and phenylalanine systems and additional biomarker assays in validation or clinical testing. Qlife is also pursuing international expansion through a strategic collaboration with Hipro Biotechnology, particularly in China, while seeking broader IVD and distribution partnerships in Europe and the United States.